Profile
IXHL TAK ZTS HLN TEVA VTRS
Company Name Incannex Healthcare Limited Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $11.86M $57.75B $56.15B $49.48B $39.35B $14.94B
Employees 0.01K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Joel Bradley Latham Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
IXHL TAK ZTS HLN TEVA VTRS
Quant Rating Score 3 3 3 4 3 2
Quant Rating Neutral Neutral Neutral Buy Neutral Sell
Trading
IXHL TAK ZTS HLN TEVA VTRS
Last Close $0.3393 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $2.21 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $0.08 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High -84.65 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 324.13 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
IXHL TAK ZTS HLN TEVA VTRS
1 Month Return -2.61 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return -15.15 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return 30.5 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return -80.83 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return -84 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return -84.22 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
IXHL TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.53 % 1.59 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) -186.69 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Growth
IXHL TAK ZTS HLN TEVA VTRS
Asset Growth 19.94 % -0.34 % 0.76 % 3.61 % -12.97 %
Gross Profit Growth 378.7 % 9.63 % -0.19 % 10.86 % -12.66 %
Revenue Growth 378.7 % 8.33 % -0.61 % 4.32 % -4.46 %
Revenue 3 Year - 24.31 % 19.01 % 11.71 % -16.52 %
Revenue 5 Year 2.7 % 55.65 % 33.95 % -1.27 % -39.86 %
Revenue 10 Year - 113.39 % 33.95 % -34.65 % -36.45 %
EBIT Growth -73.52 % 5.67 % 13.52 % -9.52 % -109.43 %
Net Income Growth -69.66 % 6.06 % 37.46 % 185.97 % -1259.41 %
Net Income 3 Yeari Growth Per Share -3852.51 % 27.46 % 4.91 % 155.65 % 49.38 %
Net Income 5 Yeari Growth Per Share -7109.38 % 74.46 % 122.63 % 133.65 % -1871.56 %
Net Income 10 Yeari Growth Per Share -746.44 % 370.4 % 122.63 % -33.98 % -122.71 %
Operating Income Growth 47.11 % 10.52 % 10.52 % 1131.35 % -98.68 %
Operating Cash Flow Growth (CFG) 21.03 % 25.5 % 9.57 % -35.33 % -17.74 %
Operating 3 Year CFG -1123.09 % 39.36 % 71.6 % 0.19 % -22.68 %
Operating 5 Year CFG -2203.17 % 73.18 % 196.04 % 29.24 % -40.08 %
Operating 10 Year CFG -348.58 % 420.39 % 196.04 % -77.86 % -24.47 %
EPS Growth -19.3 % 7.68 % 33.33 % 184.83 % -1262.28 %
EPS Diluted Growth -19.3 % 7.89 % 33.33 % 182.76 % -1269.98 %
Book Value Per Share -44 % -2.96 % -1.63 % 36.19 % -8.42 %
Share Holder 3 Year Equity Growth Per Share 367.29 % 9.65 % -37.97 % -2.08 % -7.88 %
Share Holder 5 Year Equity Growth Per Share 2956.3 % 85.42 % -40.16 % -24.81 % -26.41 %
Share Holder 10 Year Equity Growth Per Share 1192.58 % 301.38 % -40.16 % -80.23 % 90.51 %
Dividend Per Share Growth - 15.33 % 49.01 % - 0.45 %
Dividend 3 Year Growth Per Share - 73.18 % -49.79 % - 45.93 %
Dividend 5 Year Growth Per Share - 163.51 % -49.97 % - -
Dividend 10 Year Growth Per Share - 493.89 % -49.97 % -100 % -
Debt Growth -30.83 % -0.16 % 6.83 % -3.86 % -22.13 %
Free Cash Flow Growth 22.34 % 41.76 % 16.27 % -43.99 % -14.98 %
Updated On 30 Jun 2025 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
IXHL TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 100 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -291.99 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -831.86 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM -283.6 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 100 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 156.37 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -19581.16 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -3473.26 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 0.04 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM - 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM - 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 40.2 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 0.95 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -0.26 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -0.26 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 43.65 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -4595.69 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.46 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -3473.26 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -1.33 9.51 25.07 38.08 26.14 9.34
Price To Operating Cash Flows Ratio TTM -1.32 7.89 19.35 35.1 19.64 7.62
Price Cash Flow Ratio TTM -1.32 7.89 19.35 35.1 19.64 7.62
Income Statement (TTM)
IXHL TAK ZTS HLN TEVA VTRS
Revenue $0B $4581.55B $9.47B $11.23B $17.26B $14.74B
Gross Profit $0B $3001.33B $0B $6.95B $8.94B $5.62B
Gross Profit Ratio 100% 65.51% 0% 61.85% 51.79% 38.15%
EBITDA $-0.05B $1210.51B $0B $2.51B $3.14B $2.82B
Net Income $-0.05B $107.93B $2.67B $1.44B $1.41B $-0.63B
EPS Diluted -1.36 33.62 6.02 0.32 1.2 -0.53
Balance Sheet (MRQ)
IXHL TAK ZTS HLN TEVA VTRS
Long Term Debt $0B $3966.33B $0.2B $8.62B $15.56B $14.22B
Total Liabilities $0.01B $7312.37B $12.14B $18.09B $32.83B $22.87B
Total Equity $0.01B $6935.98B $3.33B $16.22B $7.91B $18.64B
Total Investments $0B $382.4B $0B $0.14B $0B $1.7B
Total Debt $0B $4515.27B $0.2B $10.1B $17.38B $14.31B
Total Assets $0.02B $14248.34B $15.47B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
IXHL TAK ZTS HLN TEVA VTRS
Net Income $-0.05B $107.93B $2.67B $1.44B $1.42B $-0.63B
Inventory $0B $-34.97B $-0.2B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-302.5B $-0.89B $-0.57B $0B $-0.57B
Operating Cash Flow $-0.01B $1057.18B $2.9B $2.3B $1.65B $2.3B
Capital Expenditure $-0B $-200.8B $-0.62B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.36
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.89
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 4.71
ALVOW Alvotech 0.3878
AMPH Amphastar Pharmaceuticals, Inc. 27.55
AMRX Amneal Pharmaceuticals, Inc. 14.63
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 76.7
APUS Apimeds Pharmaceuticals US, Inc 1.1
AQST Aquestive Therapeutics, Inc. 3.75
ASRT Assertio Holdings, Inc. 12.21
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.64
ETFs With Exposure to IXHL
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 336.01
MJ ETFMG Alternative Harvest ETF 0.13 24.98
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 113.17
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 113.15
POTX Global X Cannabis ETF 0 5.15
VTSAX Vanguard Total Stock Market Index Fund 0 163.59
VITSX Vanguard Total Stock Market Index Fund 0 163.62
MJUS ETFMG U.S. Alternative Harvest ETF 0.06 0.7595
PSIL AdvisorShares Psychedelics ETF 1.09 16.108
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 306.93
Unlock